Impact of immunosuppressive therapy on recurrence of hepatitis C.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 12362294)

Published in Liver Transpl on October 01, 2002

Authors

Gregory T Everson1

Author Affiliations

1: Hepatology, University of Colorado School of Medicine, Denver, CO 80262, USA. greg.everson@ucshc.edu

Articles citing this

Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J Virol (2009) 1.92

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24

Overview of immunosuppression in liver transplantation. World J Gastroenterol (2009) 0.96

Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol (2011) 0.91

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study. Dig Dis Sci (2010) 0.88

Treatment of hepatitis C virus infection. World J Gastroenterol (2007) 0.87

Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol (2013) 0.78

Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. J Surg Res (2011) 0.76

Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy. J Clin Transl Hepatol (2016) 0.75

Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation. Proc (Bayl Univ Med Cent) (2011) 0.75

Treatment of chronic hepatitis C in patients with Crohn's disease. Gastroenterol Hepatol (N Y) (2010) 0.75